A study directed towards exploring the temperature-dependent reactivity of the chlorine atoms of 2,4,6-trichloro-s-triazine (TCT) in the nucleophilic displacement reaction, allowed a facile replacement of its chlorine atoms in succession with (i) N-amino methyl substituted isatin-3-hydrazones, (ii) N 1 -substituted-4-amino benzene sulphonamides, and (iii) 8-amino-4-oxo-N-benzyl-azacarbazole to produce the corresponding 2,4,6-trisubstituted-s-triazine, namely; 2-(N-amino methyl substituted isatin-3-hydrazinyl)-4-(N 1 -substituted-4 � -amino benzenesulfonamidyl)-6-(8 � -amino-4 � -oxo-N-benzylazacarbazolyl)-1,3,5-triazine derivatives in acceptable yields. e compounds prepared were further evaluated for their antibacterial activity against E. coli and B. subtilis and antifungal activities against A. niger and A. �avus, and some of them showed promising activity pro�le.
Introduction
Due to rapid development in drug resistance, tolerance, and side effects, there is a critical need for the development of a new generation of antimicrobial agents that exhibit improved pharmacological properties and drug-resistance pro�les. In this aspect substituted s-triazine derivatives have been received central attention due to their signi�cant antimicrobial [1] , antibacterial [2] , antifungal [3] , anti-HIV [4] , anticancer [5] , and a wide array of other biological activities [6, 7] . Our hypothesis is to incorporate the certain pharmacophoric features and scaffolds on the templates of s-triazine molecule in order to design as a novel antimicrobial agents.
Mannich bases of isatin derivatives have been reported to form an integral part of the bioactive molecules exhibiting wide range of activities such as cytotoxic [8] , anticonvulsant [9] , antidepressant [10] , and anti-in�ammatory [11] agents. Sulphonamides have been widely known in the literature to exhibit a broad range of biological activities [12, 13] . e SO 2 -NH group of sulphonamide constitutes a key structural motif shared by a large number of bioactive compounds spanning a variety of effects such as the microbial activities [14] , speci�c enzyme inhibition [15] and hormonal regulation [16] .
e ubiquitous presence of azacarbazoles and pyridocarbazoles in a vast array of biologically active molecules (such as ellipticine, olivacine and carbaquinacine [17] , to name a few) have stimulated as intense research efforts to the synthesis of their structural analogues where different constitution and biological activity of new materials could allow them to be used as novel chemotherapeutic agents.
�reatly encouraged by the biological pro�les of these heterocyclic scaffolds, we aimed in the present work to synthesize 2,4,6-trisubstituted-s-triazine molecules incorporating in them the structural features of (i) N-Mannich's bases of isatin-3-hydrazones, 2(a-f), (ii) established sulpha drugs, 4(a,b), (iii) N-benzyl-4-oxo azacarbazole derivatives (6), on the premise that their presence in tandem in a single molecular framework in 7(a-l) should contribute signi�cantly to the biological activity in the resulting molecules and should allow them to be used as novel chemotherapeutic agents.
Preparation of 3-(2-(4,6-dichloro-1,3,5-triazin-2-yl)hydrazono)-1-(morpholinomethyl)indolin-2-one
(3a). Cyanuric chloride (1) (0.5 g, 0.002 moles) was taken in dry THF containing K 2 CO 3 (0.1 g). 1-(morpholinomethyl)indolin-2-one-3-hydrazone (2a) (0.7 g, 0.002 moles) was added to it. Reaction was kept on stirring at 0-5 ∘ C for 2-3 hr. Reaction mixture was poured in crushed ice and neutralized with dil. HCl. e resulting solid was �ltered, washed with dil. Ethanol. e resultant solid was dried and recrystallized from ethanol : water (1 : 9) mixture to give 3a, 0. Compound 3(b-f) was prepared by a similar method using appropriate reactants with required change in stirring time. Compound 5(b-l) were prepared by a similar method using appropriate reactants with required change in temperature and stirring time. 
3-(2-(
4,6-dichloro-1,3,5-triazin-2-yl)hydrazono)-1-(piperid- in-1-ylmethyl)indolin-2-one (3b
Preparation of 4-(4-chloro-
6-(2-(1-(morpholino- methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2- ylamino)-N-(thiazol-2-yl)
4-(4-chloro-
6-(2-(1-(morpholinomethyl)-2-oxoindolin-3-yl- idene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methylpy- rimidin-2-yl)benzenesulfonamide (5b
6-(2-(2-oxo-1-(piperidin-1-ylmethyl)indolin-3- ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methyl- pyrimidin-2-yl)benzenesulfonamide (5d
4-(4-chloro-6-(2-(2-oxo-1-(pyrrolidin-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (5e)
.
4-(4-chloro-6-(2-(2-oxo-1-(pyrrolidin-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methylpyrimidin-2-yl)benzenesulfonamide (5f

4-(4-chloro-6-(2-(1-((4-methylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (5g
4-(4-chloro-6-(2-(1-((4-methylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methylpyrimidin-2-yl)benzenesulfonamide (5h
4-(4-chloro-6-(2-(1-((4-ethylpiperazin-
1-yl)methyl)-2-oxo- indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N- (thiazol-2-yl)benzenesulfonamide (5i
4-(4-chloro-6-(2-(1-((4-ethylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methylpyrimidin-2-yl)benzenesulfonamide (5j
4-(4-chloro-6-(2-(2-oxo-1-((4-phenylpiperazin-1-yl)methyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (5k
4-(4-chloro-6-(2-(2-oxo-1-((4-phenylpiperazin-1-yl)methyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(4-methylpyrimidin-2-yl)benzenesulfonamide (5l
Preparation of 4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-7-ylamino)-6-(2-(1-(morpholinomethyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 7(a).
Compound 5a (0.1 g, 0.00015 moles) was taken in dry THF and K 2 CO 3 (0.1 g). N-benzyl-8-amino-azacarbazole-4-one (6) (0.046 g, 0.00015 moles) was added to this. Reaction mixture was re�uxed at 60-65 ∘ C for 6 hrs and was then poured in to crushed ice and neutralized with dil. HCl. e resulting solid was �ltered, washed with dil. �thanol. e resultant solid was dried and recrystallized from ethanol : water (1 : 9) Compound 7(b-l) were prepared by a similar method using appropriate reactants. 1-benzyl-4-oxo-2,3,4 ,5-tetrahydro-1H-pyrido [3,2- (4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b]  indol-9-ylamino)-6-(2-(1-((methylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methylpyrazin-2-yl) 
4-(4-(
b] indol-7-ylamino)-6-(2-(1-(morpholinomethyl)-2-oxoindolin- 3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methyl- pyrazin-2yl) benzenesulfonamide (7b
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-7-ylamino)-6-(2-(2-oxo-1-(piperidine-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (7c
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-7-ylamino)-6-(2-(2-oxo-1-(piperidine-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methylpyrazin-2-yl)benzenesulfonamide (7d
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(2-oxo-1-(pyrrolidine-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (7e
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(2-oxo-1-(pyrrolidine-1-ylmethyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methylpyrazin-2-yl)benzenesulfonamide (7f
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(1-((4-methylpiperazin-1-yl)methyl)-2-oxoindolin-3ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6thiazol-2-yl)benzenesulfonamide (7g
4-
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(1-((4-ethylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (7i)
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(1-((4-ethylpiperazin-1-yl)methyl)-2-oxoindolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methylpyrazin-2-yl)benzenesulfonamide (7j
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(2-oxo-1-((4-phenylpiperazin-1-yl)methyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(thiazol-2-yl)benzenesulfonamide (7k)
4-(4-(1-benzyl-4-oxo-2,3,4,5-tetrahydro-1H-pyrido [3,2-b] indol-9-ylamino)-6-(2-(2-oxo-1-((4-phenylpiperazin-1-yl)methyl)indolin-3-ylidene)hydrazinyl)-1,3,5-triazin-2-ylamino)-N-(6-methylpyrazin-2-yl)benzenesulfonamide (7l
Biological Assay
Among all of the synthesized compounds, compounds 7(a-l) were screened for antimicrobial activity by disc diffusion method [18] . e test compounds 7(a-l), in measured quantities, were dissolved in dimethyl formamide (DMF) to get the �nal concentrations 400 mg/�, 200 mg/�, 100 mg/� respectively. e bacterial (24 h) and fungal (48 h) cultures from the slants were diluted with sterile water and mixed thoroughly to prepare a clear homogeneous suspension. ese suspensions were spread on solidi�ed agar (NA-nutrient agar-for bacteria and PDA-potato dextrose agar for fungi) medium. e �lter paper disks [18] prepared by only DMF (as a negative control) and with solutions of different concentrations of test compounds 7(a-l) as well as standard compounds (cipro�oxacin and �uconazole as positive control) were carefully placed over the spread cultures and incubated at 37 ∘ C for 24 hr for bacteria and at 28-30 ∘ C for 48 hr for fungi. Aer the incubation period, the plates were examined for the zone of inhibition. e diameter for the zones of inhibition were measured including the diameter of disk also. All determinations were made in triplicate for each of the compound and the average value was taken. e antibacterial and antifungal activity was evaluated against E. coli, B. subtilis, A. niger, and A. �a�us against the standard drugs cipro�oxacin for bacteria and �uconazole for fungi. e outcome of this study is presented in Table 1 and in Figures  1-4 .
Results and Discussion
e synthetic approach which allowed the incorporation of the aforementioned bioactive heterocyclic systems on to the 2, 4, and 6 positions of s-triazine molecule was con�ned to three series outlined in Schemes 1, 2, and 3. e �rst series was derived from isatin which afforded its hydrazone from the reaction with hydrazine hydrate. Scheme 1 shows the synthetic strategy applied to obtain 3(a-f) by replacing one of the chlorine atoms of s-triazine (1) with isatinyl-3-hydrazone Mannich's bases 2(a-f), by conducting the reaction in Dry THF/K 2 CO 3 at 0-5 ∘ C for 2-3 hrs. Replacement of chlorine atoms of s-triazine is a temperature dependent nucleophilic substitution reaction [19] . While the second series was derived by the replacement of one of the chlorine atoms of 3(a-f) with two established sulpha drugs 4(a,b), consisting of sulphathiazole and sulphamerazine respectively,to yield of 5(a-l) by conducting the reaction in THF/K 2 CO 3 at 30-35 ∘ C for 2-3 hrs. L  7a  20  12  7  27  16  12  16  9  3  26  18  13  7b  15  10  6  18  10  8  18  10  4  22  17  10  7c  17  13  8  21.5  11  9  22  16  6  25  15  11  7d  16  9  3  22  12  8  20  12  8  28  20  15  7e  19  10  2  25  15  11  13  9  6  22  14  9  7f  22  16  6  19  13  9  18  6  8  15  10  10  7 g  18  10  4  22  17 e third series which consisted of the target compounds 7(a-l), was derived by replacement of the last chlorine atom of 5(a-l) with N-benzyl-8-amino-azacarbazole-4-one derivative (6). e reaction was carried out in THF/K 2 CO 3 medium at 60-65 ∘ C for 6 hrs. as shown in Scheme 3. Compound, N-benzyl-8-amino-azacarbazole-4-one (6) required in the preparation of the target compounds, 7(a-l), was synthesized from p-acetamido benzene diazonium chloride (8) following the strategy shown in Scheme 4. e reaction of 8 when allowed to take place with 3-hydroxy methylidene-N-benzyl-4-piperidone (9) under the conditions of Japp-Klingeman [20] reaction afforded the corresponding hydrazone 10, from which 6 resulted on Fischer indolization with Kent's reagent [AcOH : HCl, 4 : 1, v/v] followed by subsequent hydrolysis with acid. e antibacterial and antifungal activity was evaluated against E. coli, B. subtilis, A. niger, and A. �a�us against the standard drugs cipro�oxacin for bacteria and �ucona-zole for fungi. e zone of inhibition was measured in mm, on three different concentrations 400 mg/L, 200 mg/L, 100 mg/L. Maximum inhibitory activity was observed for 400 mg/L and compounds showed their effect in a dosedependent manner. e compound 7f was found to be most potent against B. subtilis, while the compound 7a and 7i these were found to be equipotent remaining compounds also showed the promising antibacterial activity. e compounds 7a, 7i these were most potent against E. coli while the compound 7e and 7h these were equipotent against the same strain as shown in Figures 1 and 2 . e compounds 7c and 7d, these showed promising activity against A. niger and A. �a�us respectively, while the remaining compounds also showed promising inhibitory activity as shown in Figures 3 and 4 . e morpholine, pyrrole ring, and thiazole ring were found more potent in their inhibitory effect on growth of both bacterial and fungal strains which indicates the positive modulator effect of electro negativity on activity in these molecules.
Conclusion
We developed novel trisubstitute triazine derivatives containing, N-Mannich bases of isatin-3-hydrazones, established sulpha drugs and N-benzyl-4-oxo azacarbazole derivatives using nucleophilic substitution reaction, Japp-Klingmann, Fischer-indolization, and other reactions. Furthermore, it was found that the morpholine, pyrrole ring, and thiazole ring derivatives 7a, 7i, and 7h were more potent in their inhibitory effect on growth of both bacterial and fungal strains which indicates the positive modulator effect of electronegativity on activity in these molecules. eir further quantitative structure relationship (QSAR) studies are currently under investigation.
